Detalhe da pesquisa
1.
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Ann Oncol
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834388
2.
Does vibration frequency and location influence the effect of neck muscle vibration on postural sway? A cross-sectional study in asymptomatic participants.
Exp Brain Res
; 241(9): 2261-2273, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552270
3.
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients.
Ann Oncol
; 33(4): 434-444, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066105
4.
The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
Ann Oncol
; 32(10): 1236-1244, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311075
5.
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Ann Oncol
; 31(11): 1491-1505, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853681
6.
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.
Semin Cancer Biol
; 52(Pt 2): 151-157, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29990622
7.
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
Ann Oncol
; 30(12): 1941-1949, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566659
8.
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Ann Oncol
; 30(2): 236-242, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590484
9.
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ann Oncol
; 30(11): 1784-1795, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591636
10.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.
Ann Oncol
; 29(1): 162-169, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077781
11.
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary.
Ann Oncol
; 29(1): 30-35, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29140430
12.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.
Ann Oncol
; 29(8): 1755-1762, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893769
13.
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
Ann Oncol
; 28(7): 1523-1531, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633480
14.
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region.
Public Health
; 149: 81-88, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577441
15.
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.
Ann Oncol
; 27(12): 2160-2167, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634691
16.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.
Ann Oncol
; 27(10): 1860-6, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27672107
17.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.
Ann Oncol
; 27(6): 1029-1034, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26961151
18.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 873-879, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25725046
19.
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
Ann Oncol
; 25(8): 1544-50, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608200
20.
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.
Ann Oncol
; 25(10): 1959-1965, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185240